Cite
APA Citation
Manwani, R., Mahmood, S., Sachchithanantham, S., Lachmann, H. J., Gillmore, J. D., Yong, K., Rabin, N., Popat, R., Kyriakou, C., Worthington, S., Sharpley, F., Smith, M., Shah, R., Cheesman, S., Hawkins, P. N., & Wechalekar, A. D. (2019). carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British journal of haematology, 187, 638–641. http://access.bl.uk/ark:/81055/vdc_100095342868.0x000062